Norge - norsk - Statens legemiddelverk

b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon

Norge - norsk - Statens legemiddelverk

b. braun melsungen ag - glukosemonohydrat / natriumfosfatdihydrat / sinkacetatdihydrat / triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider / isoleucin / leucin / lysinhydroklorid / metionin / fenylalanin / treonin / tryptofan / valin / arginin / histidinhydrokloridmonohydrat / alanin / aspartinsyre / glutaminsyre / glysin / prolin / serin / natriumhydroksid / natriumklorid / natriumacetattrihydrat / kaliumacetat / magnesiumacetattetrahydrat / kalsiumkloriddihydrat - infusjonsvæske, emulsjon

Den europeiske union - norsk - EMA (European Medicines Agency)

virbac s.a. - rekombinant omega interferon av feline opprinnelse - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. hos katter infisert av fiv var dødeligheten lav (5%) og ble ikke påvirket av behandlingen.

Den europeiske union - norsk - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Norge - norsk - Statens legemiddelverk

oresund pharma aps - ganciklovirnatrium - pulver til konsentrat til infusjonsvæske, oppløsning - 500 mg

Norge - norsk - Statens legemiddelverk

basf - omega-3-syreetylestere 90 - kapsel, myk - 1000 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

teva b.v.  - lamivudin - hiv-infeksjoner - antivirale midler til systemisk bruk - lamivudin teva pharma b. indikeres som en del av antiretroviral kombinationsbehandling for behandling av humane immunsviktvirus (hiv) -infiserte voksne og barn.

Den europeiske union - norsk - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.

Norge - norsk - Statens legemiddelverk

mylan ab - abakavirsulfat / lamivudin - tablett, filmdrasjert - 600 mg / 300 mg

Norge - norsk - Statens legemiddelverk

b. braun melsungen ag - triglyserider av middels kjedelengde / soyaolje, renset / omega-3-syretriglyserider - infusjonsvæske, emulsjon